Literature DB >> 30207913

ECMO for Severe Acute Respiratory Distress Syndrome.

Alain Combes1, Arthur S Slutsky2, Daniel Brodie3.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 30207913     DOI： 10.1056/NEJMc1808731

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  5 in total

Review 1.  [Indications and limitations of ECMO therapy : Considerations on evidence, treatment decisions and ethical challenges].

Authors:  C Karagiannidis; T Bein; S Weber-Carstens
Journal:  Med Klin Intensivmed Notfmed       Date:  2019-02-05       Impact factor: 0.840

2.  Lung perfusion during veno-venous extracorporeal membrane oxygenation in a model of hypoxemic respiratory failure.

Authors:  Pedro Vitale Mendes; Marcelo Park; Luciano Cesar Pontes de Azevedo; Caio Cesar Araujo Morais; Marcelo Brito Passos Amato; Eduardo Leite Vieira Costa
Journal:  Intensive Care Med Exp       Date:  2022-04-25

3.  Validation of RESP and PRESERVE score for ARDS patients with pumpless extracorporeal lung assist (pECLA).

Authors:  Jan Petran; Thorsten Muelly; Rolf Dembinski; Niklas Steuer; Jutta Arens; Gernot Marx; Ruedger Kopp
Journal:  BMC Anesthesiol       Date:  2020-05-02       Impact factor: 2.217

Review 4.  Decompressive hemicraniectomy for acute ischemic stroke: A neurosurgical view in a pandemic COVID-19 time highlights of literature.

Authors:  Luiz Severo Bem Junior; Otávio da Cunha Ferreira Neto; Artêmio José Araruna Dias; Joaquim Fechine de Alencar Neto; Luís Felipe Gonçalves de Lima; Nilson Batista Lemos; Andrey Maia Silva Diniz; Kaio Moreira Couto; Jorge Henrique Estrela Gadelha Maia; Ana Cristina Veiga Silva; Hildo Rocha Cirne de Azevedo Filho
Journal:  Interdiscip Neurosurg       Date:  2022-01-07

5.  Use of Almitrine and Inhaled Nitric Oxide in ARDS Due to COVID-19.

Authors:  Driss Laghlam; Ghilas Rahoual; Julien Malvy; Philippe Estagnasié; Alain Brusset; Pierre Squara
Journal:  Front Med (Lausanne)       Date:  2021-07-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.